ARCHED - GLA 2022-1

 

Rekrutierung beginnt in Kürze

A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma

 
Zusätzliche Dokumente